Director/PDMR Shareholding

Source: RNS
RNS Number : 9089K
IntegraFin Holdings plc
07 September 2021
 

IntegraFin Holdings plc (the "Company")

Notification and public disclosure of a transaction by a person discharging managerial responsibilities ("PDMR")

The Company announces that Michael Howard, an executive director/PDMR has disposed of 3,538,247 ordinary shares of £0.01 on 6 September 2021. The sale was instructed, primarily, to enable Michael Howard to further fund a charitable foundation and, residually, for diversification purposes. Michael Howard continues to be a director of the Company and his working relationship with the group is unchanged.

 

The Notification of Dealing Forms follow. These notifications are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Michael Howard

2.

Reason for the notification

 

a)

Position/status

PDMR - Executive Director

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

IntegraFin Holdings plc

b)

LEI

213800CYIZXK9PQYE87

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares of £0.01 each

 

GB00BD45SH49

b)

Nature of the transaction

Sale

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 £5.63

3,538,247

d)

Aggregated information

 


-     Aggregated volume

 

-     Price

 


N/A



e)

Date of the transaction

 6 September 2021

f)

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBQLLBFKLFBBZ